A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease by Ostrowitzki, Susanne, Lasser, Robert A, Dorflinger, Ernest, Scheltens, Philip, Barkhof, Frederik, Nikolcheva, Tania, Ashford, Elizabeth, Retout, Sylvie, Hofmann, Carsten, Delmar, Paul, Klein, Gregory, Andjelkovic, Mirjana, Dubois, Bruno, Boada, Mercè, Blennow, Kaj, Santarelli, Luca, Fontoura, Paulo

Get full text

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease by Ostrowitzki, Susanne, Lasser, Robert A, Dorflinger, Ernest, Scheltens, Philip, Barkhof, Frederik, Nikolcheva, Tania, Ashford, Elizabeth, Retout, Sylvie, Hofmann, Carsten, Delmar, Paul, Klein, Gregory, Andjelkovic, Mirjana, Dubois, Bruno, Boada, Mercè, Blennow, Kaj, Santarelli, Luca, Fontoura, Paulo

Get full text

CSF and amyloid pet biomarker data from scarlet road - a global Phase 3 study of gantenerumab in patients with prodromal AD by Nikolcheva, Tania, Lasser, Robert, Ostrowitzki, Susanne, Scheltens, Philip, Boada, Merce, Dubois, Bruno, Dorflinger, Ernest, Volz, Dietmar, Eichenlaub, Udo, Rabe, Christina, Bittner, Tobias, Schmitz, Markus, Edgar, Chris, Garibaldi, George, Fontoura, Paulo, Santarelli, Luca

Get full text

Alzheimer’s disease therapeutic trials: EU/US task force report on recruitment, retention, and methodology by Vellas, B, Hampel, H, Rouge-Bugat, M. E, Grundman, M, Andrieu, S, Abu-Shakra, S, Bateman, R, Berman, R, Black, R, Carrillo, M, Donohue, M, Mintun, M, Morris, J, Petersen, R, Thomas, R. G, Suhy, J, Schneider, L, Seely, L, Tariot, P, Touchon, J, Weiner, M, Sampaio, C, Aisen, P

Get full text

Illness impact and adjustment to Parkinson's disease: Before and after treatment with tolcapone by Welsh, Mickie D., Dorflinger, Ernest, Chernik, Doris, Waters, Cheryl

Get full text

A physical chemistry experiment in Mossbauer spectroscopy by Armstrong, William H, Dorflinger, Ernest E, Anderson, Owen T, Willeford, Bennett R

Get full text